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Abstract
Current epidemics of diabetes mellitus is largely caused by wide spread obesity. The best-established connection between
obesity and insulin resistance is the elevated and/or dysregulated levels of circulating free fatty acids that cause and
aggravate insulin resistance, type 2 diabetes, cardiovascular disease and other hazardous metabolic conditions. Here, we
investigated the effect of a major dietary saturated fatty acid, palmitate, on the insulin-sensitizing adipokine adiponectin
produced by cultured adipocytes. We have found that palmitate rapidly inhibits transcription of the adiponectin gene and
the release of adiponectin from adipocytes. Adiponectin gene expression is controlled primarily by PPARc and C/EBPa.
Using mouse embryonic fibroblasts from C/EBPa-null mice, we have determined that the latter transcription factor may not
solely mediate the inhibitory effect of palmitate on adiponectin transcription leaving PPARc as a likely target of palmitate. In
agreement with this model, palmitate increases phosphorylation of PPARc on Ser273, and substitution of PPARc for the
unphosphorylated mutant Ser273Ala blocks the effect of palmitate on adiponectin transcription. The inhibitory effect of
palmitate on adiponectin gene expression requires its intracellular metabolism via the acyl-CoA synthetase 1-mediated
pathway. In addition, we found that palmitate stimulates degradation of intracellular adiponectin by lysosomes, and the
lysosomal inhibitor, chloroquine, suppressed the effect of palmitate on adiponectin release from adipocytes. We present
evidence suggesting that the intracellular sorting receptor, sortilin, plays an important role in targeting of adiponectin to
lysosomes. Thus, palmitate not only decreases adiponectin expression at the level of transcription but may also stimulate
lysosomal degradation of newly synthesized adiponectin.
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Introduction
Major discoveries of the last 15 years have established fat as an
important secretory tissue. It is now clear that adipokines regulate
central aspects of metabolism, such as body weight, energy
expenditure, insulin sensitivity and a variety of physiological
conditions which are directly or indirectly associated with these
parameters. In particular, adiponectin that is generally considered as
one of the most abundant and functionally significant adipokines
improveswholebodyinsulinsensitivityandglucosetolerance[1,2,3].
Unlike many other adipokines, secretion of adiponectin is
decreased in obesity [1,4,5,6,7]. This observation is highly
significant because it may help to understand a long-known
connection between obesity, insulin resistance and diabetes, a
disease that has reached pandemic proportions in the recent years
[8]. In further support of this model, adiponectin has been shown
to improve insulin resistance associated with obesity [9,10]. This
suggests that a decrease in adiponectin production in obese
individuals may represent an important causative factor in the
development and/or propagation of the insulin resistance,
diabetes, and, potentially, other metabolic diseases.
How exactly excess fat suppresses production of adiponectin is
not understood mechanistically. However, since obesity is usually
accompanied by elevated levels of circulating fatty acids and, in
particular, saturated fatty acids (SFA), such as palmitate, the
negative effect of obesity on adiponectin may be attributed to the
direct action of fatty acids on adipocytes [11,12,13]. In agreement
with this hypothesis, we have found that palmitate inhibits
adiponectin production by adipocytes in a cell-autonomous
fashion. Interestingly, palmitate exerts its effect on fat cells at
different levels. First, palmitate rapidly decreases adiponectin
transcription. This effect is associated with phosphorylation of
PPARc on Ser273. In addition, palmitate may increase degrada-
tion of de novo synthesized adiponectin in lysosomes via a sortilin-
mediated mechanism.
Results
Metabolic products of palmitate inhibit adiponectin
expression at the level of transcription
Fig. 1A shows that palmitate at a concentration of 300–500 mM
strongly decreases secretion of adiponectin from 3T3-L1 adipo-
cytes. Although blood levels of palmitate in vivo vary within 100–
150 mM [14], the total concentration of free fatty acids may
significantly exceed 1 mM [15,16], so palmitate concentrations
used in our study may not be far from physiological.
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production at the level of gene expression, we have measured
levels of adiponectin mRNA in palmitate-treated and not treated
adipocytes by qPCR. As is shown in Fig. 1B, palmitate decreases
adiponectin mRNA in a time-dependent fashion. In all following
experiments, we have incubated adipocytes with palmitate for no
longer than 4 h, because at this time point palmitate does not
affect mRNAs for PPARc and C/EBPa (Fig. 1C) – the two major
transcription factors that control expression of the adiponectin
gene [17]. Although we determined that oleate also inhibited
adiponectin expression and secretion (Fig. S1), in this study, we
decided to focus on the effect of a common dietary saturated fatty
acid, palmitate.
The adiponectin promoter has several C/EBPa enhancer
elements [17]. To determine if the effect of palmitate on
adiponectin gene expression is mediated by C/EBPa, we used
differentiated mouse embryonic fibroblasts obtained from C/
EBPa–null mice [18]. Note, that these cells express detectable
levels of PPARc (Fig. 2). Although total adiponectin expression in
these cells was decreased (not shown), we found that palmitate was
still able to suppress expression of adiponectin mRNA (Fig. 2),
suggesting that C/EBPa may not be solely responsible for this
effect. Therefore, we decided to test an alternative hypothesis that
palmitate decreases expression of adiponectin mRNA via PPARc.
In agreement with several previously published reports
summarized in [17], we found that over-expression of PPARc
increases, while knock down of PPARc – decreases adiponectin
mRNA (not shown) which confirmed the involvement of PPARc
in regulation of the adiponectin gene expression. A recent study
from the Spiegelman’s laboratory, suggested that adiponectin
transcription may be regulated by Cdk5-mediated phosphoryla-
tion of PPARc on Ser273 [19]. In agreement with this report, we
have found that palmitate stimulates phosphorylation of PPARc
on Ser273 (Fig. 3A). To determine whether this phosphorylation
event is sufficient to convey the negative effect of palmitate on
adiponectin transcription, we used differentiated Swiss fibroblasts
stably transfected with wild type PPARc or unphosphorylatable
mutant of PPARc where Ser273 was substituted for Ala. As is
shown in Fig. 3B, the extent of differentiation of both cell lines was
identical as judged by the expression levels of several differenti-
ation markers: PPARc, C/EBPa, perilipin, and FABP4. Interest-
ingly, palmitate decreased adiponectin transcription in the former
cell line but not in the latter (Fig. 3C).
Thus, phosphorylation of PPARc on Ser273, presumably by
Cdk5 [19], may be responsible for the effect of palmitate on the
adiponectin gene expression. However, the upstream mechanism
of palmitate action remains unknown. According to one model,
Figure 1. Palmitate decreases adiponectin expression and secretion. (A) Differentiated 3T3-L1 adipocytes were incubated with and without
palmitate for 4 hours, and the presence of adiponectin in cell media was analyzed by Western blotting. Intracellular actin was used as a loading
control. (B) Adiponectin mRNA in 3T3-L1 adipocytes incubated with and without 500 mM of palmitate for indicated periods of time. (C) Expression
levels of mRNAs for adiponectin, PPARc, and CEBPa in differentiated 3T3-L1 adipocytes incubated in the presence and in the absence of 500 mM
palmitate for 4 hours. In (B) and (C), mRNA was analyzed by quantitative PCR and normalized by 36B4. Data were expressed as mean 6 S.D. * p,0.05;
** p,0.001.
doi:10.1371/journal.pone.0028146.g001
Figure 2. Palmitate decreases adiponectin mRNA in C/EBPa null
mouse embryonic fibroblasts. Top panel: Differentiated MEFs from
C/EBPa null mice were incubated with and without 500 mM palmitate
for 4 h, and adiponectin mRNA was analyzed by quantitative PCR and
normalized by 36B4. Data were expressed as mean 6 S. D. * p,0.05.
Bottom panels: cell lysate was prepared from C/EBPa null MEFs and
analyzed by Western blotting (35 mg of total protein per lane).
doi:10.1371/journal.pone.0028146.g002
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and trigger a signal transduction pathway that leads to
phosphorylation of PPARc on Ser273. On the other hand,
palmitate may penetrate inside the cell and become converted into
lipid products, such as palmityl-CoA, diacylglycerol or ceramide.
These compounds induce multiple cellular responses, such as
activation of protein kinases C and IkB, stimulation of ROS
production, ER stress, etc. that are collectively known as
lipotoxicity [22,23,24,25].
The first step of FA metabolism is the conversion into acyl-CoA
by the family of enzymes called acyl-CoA synthetases [26]. In
particular, palmitate is the preferential substrate for acyl-CoA
synthetase 1, or ACSL1, the major acyl-CoA synthetase in
adipocytes [26]. Thus, in order to determine whether the effect of
palmitate on adiponectin gene expression represents the result of
the activation of the cell surface receptors or is caused by
intracellular lipotoxicity, we used the stable line of 3T3-L1
adipocytes where expression of ACSL1 was significantly attenu-
ated by constitutive production of a ACSL1-shRNA [27]. Note,
that FA uptake into these cells is not altered, while palmitate-CoA
synthetase activity is dramatically decreased [27].
We have found that stable knock down of ACSL1 does not
change the levels of mRNAs for PPARc and C/EBPa but
increases transcription of adiponectin (Fig. 4A). In order to
confirm this observation using an independent approach, we used
the acyl-CoA synthetase inhibitor, Triacsin C, and obtained a
similar result (Fig. 4B). Furthermore, we have determined that
palmitate does not inhibit transcription of adiponectin mRNA and
secretion of adiponectin from ACSL1-depleted cells (Fig. 5A,B).
Also, treatment of cells with Triacsin C prevents the inhibitory
effect of palmitate on adiponectin transcription and secretion
(Fig. 5C,D). Interestingly, palmitate-stimulated phosphorylation of
PPARc on Ser273 is compromised in ACSL1-depleted cells
(Fig. 6). Based on these results, we suggest that inhibition of
adiponectin gene expression by palmitate is caused by intracellular
lipotoxicity rather than by binding of palmitate to the extracellular
receptors. Such a conclusion would be consistent with a recent
paper by Loo et al. [28] demonstrating a strong negative
correlation between adiponectin expression and lipid accumula-
tion in individual sub-populations of 3T3-L1 adipocytes in vitro.
Palmitate promotes degradation of adiponectin via the
lysosomal pathway
Inhibition of gene transcription may not be the only mechanism
by which fatty acids suppress adiponectin production and secretion
from adipocytes. In fact, Nguyen et al. noticed that fatty acids
decrease adiponectin secretion within 1 hour of incubation [12].
Clearly, such a rapid effect of fatty acids may only be related
to a very late post-translational regulatory step in adiponectin
production.
As the major pool of intracellular adiponectin resides in the
endoplasmic reticulum (ER) [29,30], one such step may be export
of de novo synthesized adiponectin from the ER due to stress
imposed on ER by fatty acids [31,32,33,34]. In fact, it has been
Figure 3. Palmitate inhibits adiponectin transcription by increasing phosphorylation of PPARc on serine 273. (A) Differentiated 3T3 L1
adipocytes were serum starved for 2 hours and treated or not treated with palmitate for indicated periods of time. Cell lysates were analyzed by
Western blotting (35 mg of total protein per lane). (B) Swiss fibroblasts stably transfected with wild-type (WT) and S273A PPARc were differentiated as
described in Materials and Methods and mRNAs for PPARc, C/EBPa, perilipin and FABP4 were determined by quantitative PCR and normalized by
36B4 levels. (C) Differentiated Swiss fibroblasts stably transfected with wild-type (WT) and S273A PPARc were incubated with 500 mM of palmitate for
5 hours. Adiponectin mRNA was determined by quantitative PCR and normalized by 36B4 levels. Data were expressed as mean 6 S. D. * p,0.05.
doi:10.1371/journal.pone.0028146.g003
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stably knocked down in 3T3-L1 adipocytes with the help of shRNA (ACSL1 KD), and mRNAs for adiponectin, PPARc,a n dC E B P a were analyzed by
quantitative PCR in ACSL1 KD andcontrol(scrambledshRNA) cells.(B) Differentiatedwildtype 3T3-L1adipocyteswere incubatedwithandwithout 48 mM
of Triacsin C for 6 hours, and mRNAs for PPARc, CEBPa and adiponectin were analyzed by quantitative PCR. Data are expressed as mean 6 S. D. *p,0.05.
doi:10.1371/journal.pone.0028146.g004
Figure 5. Long-chain acyl CoA synthetase mediates the inhibitory effect of palmitate on transcription and secretion of adiponectin.
(A) ACSL1 KD and control (scrambled) adipocytes were incubated in the presence or absence of 500 mM palmitate for 4 h, and adiponectin mRNA
was analyzed by quantitative PCR and normalized by GAPDH. Data are expressed as mean 6 S. D. *p,0.05. (B) ACSL1 KD and control (scrambled)
adipocytes were incubated with indicated concentrations of palmitate for 4 h, and the presence of adiponectin in cell media was analyzed by
Western blotting. Intracellular actin was used as a loading control. (C) Wild type 3T3-L1 adipocytes were incubated with and without 500 mM
palmitate and 48 mM Triacsin C for 4 h, and adiponectin mRNA was analyzed by quantitative PCR and normalized by 36B4. Data are expressed as
mean 6 S. D. *p,0.05. (D) Wild type 3T3-L1 adipocytes were incubated with and without 500 mM palmitate and 48 mM Triacsin C for 4 h, and the
presence of adiponectin in cell media was analyzed by Western blotting. Intracellular actin was used as a loading control.
doi:10.1371/journal.pone.0028146.g005
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obesity-induced suppression of adiponectin secretion [35]. Thus,
we compared the effect of palmitate and the ER stress-inducing
antibiotic, tunicamycin, on adiponectin secretion. As is shown in
Fig. S2, both tunicamycin and palmitate decrease adiponectin
secretion from 3T3-L1 adipocytes. The effect of tunicamycin is
quite expected, as ER stress should, by definition, inhibit
biosynthesis of secretory proteins. It becomes apparent after 8 h
of incubation, likely because it takes several hours for newly
synthesized adiponectin to travel through the secretory pathway
and to be released into the media. On the contrary, palmitate
inhibits adiponectin secretion already after 3 h of incubation,
much prior to the ER stress-mediated inhibition of adiponectin
secretion. The acute effect of palmitate suggests that it may
promote degradation of de novo synthesized adiponectin in the
adipocyte. In agreement with this hypothesis, we have found that
incubation of cultured adipocytes with palmitate increases
lysosomal staining and decreases the abundance of adiponectin
in cells (Fig. 7A, B). In addition, the lysosomal inhibitor
chloroquine alleviates the inhibitory effect of palmitate on
adiponectin secretion (Fig. 7C). Thus, palmitate may stimulate
lysosomal degradation of newly synthesized adiponectin.
Mechanistically, lysosomal targeting of various proteins is
mediated by a multi-ligand receptor, sortilin [36,37,38,39,40]. In
order to determine whether or not sortilin is involved in lysosomal
degradation of adiponectin, we used 3T3-L1 adipocytes stably
over-expressing sortilin tagged with myc/His epitopes at the C-
terminus (S+ cells) and 3T3-L1 adipocytes where sortilin
expression had been knocked down with the help of shRNA (S-
cells) [41]. We found that S+ adipocytes secrete less adiponectin
than control empty vector-infected cells. Correspondingly, S-
adipocytes secrete much more adiponectin that control cells
(Fig. 8A). Apparently, these effects take place at a post-
transcriptional level, as knock down of sortilin does not change
the level of adiponectin mRNA determined by qPCR while over-
expression of sortilin increases it (Fig. 8B). Also, there were no
detectable changes in lipid accumulation and expression of
multiple differentiation markers between S+ and S- adipocytes
(not shown; see also [41]), suggesting that changes in adiponectin
secretion are not explained by differences in cell differentiation.
As Western blotting ‘‘averages’’ adiponectin secretion from a
large number of cells that may express different amounts of
exogenous sortilin, we decided to continue this work by analyzing
individual cells. For that, we performed double immunofluores-
cence staining of S+ adipocytes for sortilin and adiponectin. Using
this approach, we found that cells with the highest levels of sortilin
over-expression have virtually no adiponectin and vice versa
(Fig. 8C). Quantification of these results demonstrates that only
ca. 10% of cells over-expressing detectable amounts of exogenous
sortilin contain adiponectin (Fig. 8D). Treatment of cells with
chloroquine increased the number of S+ cells that co-express
sortilin and adiponectin 2.5-fold (from 10 +/2 6% to 25 +/2
4%). These results are consistent with the idea that a significant
fraction of intracellular adiponectin undergoes lysosomal degra-
dation via a sortilin-mediated pathway.
Discussion
Several research groups have reported that consumption of
saturated fat suppresses production of the insulin-sensitizing
adipokine adiponectin in white adipose tissue of humans and
rodents (reviewed in [42,43]. Furthermore, Fernandez-Real et al.
demonstrated a negative correlation between palmitate and
circulating adiponectin in human serum [44]. Thus, the inhibitory
effect on the production of adiponectin may represent an
important component of the diabetogenic action of saturated
fatty acids.
In order to explore the molecular mechanism of this effect, we
studied production of adiponectin by 3T3-L1 adipocytes in the
presence and in the absence of palmitate. We found that palmitate
rapidly inhibits the release of adiponectin from adipocytes. In
order to search for an explanation of this effect, we found that
palmitate inhibits transcription of the adiponectin gene. At the
same time, expression levels of mRNAs for PPARc and C/EBPa
that control adiponectin transcription do not change (Fig. 1C). In
addition, it was shown previously that palmitate did not decrease,
but on the opposite, stimulated transcription of other adipokines,
such as TNFa, IL6 [45,46] and RBP4 (results not shown). Thus,
the inhibitory effect of palmitate cannot be related to the general
action of saturated fatty acids on transcription but is specific for
transcription of adiponectin. This result is consistent with the
previous findings showing that palmitate decreases adiponectin
mRNA in adipocytes [47,48]. It is well known, however, that
isolation of primary adipocytes with the help of collagenase
digestion carried out by Xi et al. [48] down-regulates multiple
adipocyte genes in a non-specific fashion [49] rendering their
results prone to alternative interpretations. The second study [47]
demonstrated a decrease in adiponectin mRNA after 48 h
incubation with palmitate which did not exclude potential indirect
secondary effects of palmitate treatment. We studied the effect of
palmitate after a relatively short 4 h incubation period which is
likely to show a direct effect on adiponectin transcription. Still, our
results suggest that palmitate per se is not likely to affect adiponectin
gene expression. We favor the model according to which palmitate
is rapidly metabolized in an ACSL1-dependent fashion into an as
yet unidentified lipid product(s) that triggers phosphorylation of
PPARc on Ser273. Interestingly, knock down of ACSL1 increased
phosphorylation levels of PKCh and JNK – two protein kinases
that are usually thought to mediate lipotoxic effects [27].
Therefore, increased adiponectin expression in ACSL1-ablated
Figure 6. Phosphorylation of PPAR c on serine 273 is
compromised in ACSL1 KD adipocytes. ACSL1 KD and control
(scrambled) adipocytes were serum starved for 2 h, treated or not
treated with 500 mM palmitate for 30 min and analyzed by Western
blotting (35 mg of total protein per lane). Dotted lines indicate that
irrelevant lanes have been spliced out.
doi:10.1371/journal.pone.0028146.g006
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results support the model of Choi et al. [19] according to which
the effect of lipotoxicity on the adiponectin gene expression is
mediated by CDK5.
We have also found that the amount of adiponectin produced
by fat cells may be regulated at the level of protein degradation.
This effect may not be specific for adiponectin as a large fraction of
de novo synthesized secreted proteins undergoes lysosomal degra-
dation in adipocytes. For example, up to 80% of LPL molecules
newly synthesized in adipocytes entry the degradative pathway
[50,51,52,53]. In addition, up to 50% of newly synthesized leptin
is also degraded instead of being secreted [54]. Importantly,
degradation of LPL is mediated by sortilin [40]. More recently, it
has been shown that ‘‘over-production’’ and sortilin-mediated
degradation of secreted proteins is not unique to adipocytes. Thus,
sortilin mediates lysosomal degradation of members of the TGF-b
family [37] and brain-derived neurotrophic factor [36] in various
mammalian cells.
It is yet hard to tell why the cell decides to operate in such a
way; it is clear, however, that ‘‘futile cycles’’ of biosynthesis and
degradation are often seen in metabolism. One possibility is that
such mechanism may provide a faster response to rapid changes in
metabolic conditions. According to this idea, the cell may prefer to
re-route secreted proteins from degradation to secretion and vice
versa rather than to induce/suppress protein expression that takes
much longer time. Other factors, however, may also play a role.
For example, it is feasible that the secretory capacity of the
adipocyte is limited so that intracellular adipokines compete for
being released into the extracellular space. In any way, it may be
possible to take advantage of such situation in order to facilitate
the release of adipokines of our choice and to inhibit secretion of
unwanted proteins. Further experiments should uncover molecu-
lar details that are required to operate protein flows in adipocytes
and other cell types.
Materials and Methods
Antibodies
In this study, we used monoclonal antibodies against adipo-
nectin (Abcam, Cambridge, MA) and actin (Sigma Chemical Co.,
St. Louis, MO) and polyclonal antibodies against PPARc,C /
EBPa (Santa Cruz Biotechnology, Santa Cruz, CA), and myc
epitope (Cell Signaling, Danvers, MA). Polyclonal phospho-
specific antibody against pSer273 PPARc was a kind gift of Dr.
Spiegelman (Harvard Medical School).
Cell culture
Wild type 3T3-L1 cells [55], 3T3-L1 cells infected with
lentivirus carrying shRNA against ACSL1 and scrambled control
[27], 3T3-L1 cells stably expressing sortilin tagged with myc/His
Figure 7. Palmitate increases intracellular degradation of adiponectin via the lysosomal pathway. (A) Wild type 3T3-L1 adipocytes were
treated or not treated with 500 mM palmitate for 4 hours and then - with 100 nM of lysotracker (red) for 30 minutes at 37uC. Cells were fixed and
stained for adiponectin (green). (B) The ratio between lysotracker (red) and adiponectin (green) staining was determined with the help of the ImageJ
software in ca. 100 adipocytes treated and not treated with palmitate. (C) Wild type 3T3-L1 adipocytes were treated or not treated with 500 mMo f
palmitate and 20 mM of Chloroquine for 4 h as indicated, and the presence of adiponectin in cell media was analyzed by Western blotting.
Intracellular actin was used as a loading control. Dotted lines indicate that irrelevant lanes have been spliced out.
doi:10.1371/journal.pone.0028146.g007
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decreased expression of sortilin [41] were cultured, differentiated,
and maintained as described previously [56]. Briefly, cells were
cultured in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% bovine serum and 2 mmol/l L-glutamine,
100 units/ml penicillin, and 100 mg/ml streptomycin until
confluency. Forty eight hours post confluency cells were
differentiated using cocktail of insulin, dexamethasone, and
isobutylmethylxanthine in DMEM supplemented with 10% fetal
bovine serum (FBS), 2 mmol/l L-glutamine, 100 units/ml
penicillin, and 100 mg/ml streptomycin. Mouse embryonic
fibroblasts (MEFs) [18] and Swiss fibroblasts were grown in
DMEM supplemented with 10% FBS, 2 mM L-glutamine, 100
units/ml penicillin, and 100 mg/ml streptomycin. The latter were
stably transfected with the retroviral vector pBabe encoding either
wild type PPARc or S273A PPARc. All procedures have been
approved by the Institutional Biosafety Committee of Boston
University Medical School (protocol 10-011, valid till 02/25/
2013). In all secretion experiments, cells were incubated in 10%
FBS replacement media (Lifeblood Medical Institute Adelphia,
NJ) in DMEM. The stock solution of palmitate was prepared in
two different ways with no apparent differences in the biological
activity. First, palmitate was dissolved in 100% ethanol heated to
65uC to final concentration 10 mM. Alternatively, palmitate was
dissolved in chloroform at 10 mM, and chloroform was evapo-
rated under inert gas. The palmitate film was dissolved in
potassium hydroxide at 1:1.2 molar ratio of palmitate to KOH.
This solution was mixed with 20% fatty acid free BSA in PBS at
the molar ratio 3:1.
Western blot analysis
Proteins were run on SDS-polyacrylamide gels, transferred to
Immobilon-P membranes (Millipore) in 25 mM Tris, 192 mM
glycine. Following transfer, the membranes were blocked with
10% bovine serum albumin (BSA) in phosphate buffered saline
(PBS) with 0.1% Tween 20 and probed with primary antibodies.
Horseradish peroxidase-conjugated secondary antibodies (Pierce
Biotechnology, IL) and an enhanced chemiluminescence substrate
kit (Perkin-Elmer Life Sciences, MA) were used for detection of
specific proteins. Blots were developed with the help of a Kodak
Image Station 440CF (Eastman Kodak, Rochester, NY).
RNA analysis
Total cellular RNA was prepared using TRIzol reagent
(Ambion, Austin, TX) according to the manufacturer’s instruc-
tions. Reverse transcription of 1mg of total RNA was done using
random decamers (RETROscript kit; Ambion, Austin, TX), and
mRNAs for adiponectin, PPARc, C/EBPa, perilipin, FABP4,
actin, GAPDH and 36B4 were determined by qPCR using
MX4000 multiplex qPCR system (Stratagene, La Jolla, CA). All
qPCR analyses were done in samples containing 2.5 ml of 1:10
diluted cDNA, 22.5 ml of SYBR green master mix (Brilliant II
SYBR Green qPCR master mix; Stratagene), and gene-specific
primers (Operon, Huntsville, AL) in triplicate.
Immunofluorescence
3T3-L1 adipocytes were grown and differentiated in 60-mm
dishes. On day 5 of differentiation, cells were lifted up with 0.25%
trypsin for 10 min at 37uC and reseeded to 4-well chamber slides.
Figure 8. Sortilin is involved in lysosomal degradation of adiponectin. (A) Differentiated S-, S+ and control (empty vector-infected, EV)
adipocytes were cultured in FBS replacement media for indicated periods of time, and secreted adiponectin was analyzed by Western blotting. (B)
Adiponectin mRNA was analyzed in S-, S+ and control (empty vector-infected, EV) adipocytes by qPCR and normalized by actin. (C) S+ cells were
treated and not treated with 20 mM Chloroquine for 4 hours and incubated with the mixture of primary monoclonal antibody against adiponectin
and polyclonal antibody against myc overnight followed by incubation with donkey anti-mouse secondary antibody labeled with Cy3 (Jackson
Immunoresearch, ME) and donkey anti-rabbit secondary antibody labeled with Alexa Flour488 (BD Biosciences, San Jose, CA) for 1 hr. (D) The number
of cells that co-express sortilin and adiponectin with and without Chloroquine treatment was quantified and expressed as mean 6 S.D. * p,0.05.
doi:10.1371/journal.pone.0028146.g008
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were treated with 500 mM of palmitate for 4 hours and incubated
with 100 nM of lysotracker (Invitrogen, Eugene, OR) for
30 minutes at 37uC. Cells were then washed 3 times with PBS
and fixed with 4% paraformaldehyde in PBS for 30 minutes.
Fixed cells were permeabilized with 0.2% Triton X-100 for 5
minutes and blocked with 5% donkey serum and 5% BSA for
1 hour. Cells were stained with primary monoclonal antibody
against adiponectin overnight followed by secondary DyLight 488-
coupled goat anti-mouse antibody (Jackson Immunoresearch, ME)
at room temperature for 1 hour. Slides were mounted using
Vectashield (Vector Laboratories, Burlingame, CA) and visualized
with the help of Carl Zeiss immunofluorescent microscope Axio
Observer Z1 (Germany).
Statistics
Students paired two-tailed t-test was used to evaluate the
statistical significance, and results were considered significant with
the p value ,0.05.
Supporting Information
Figure S1 Oleate decreases adiponectin expression and
secretion. (A) Differentiated 3T3-L1 adipocytes were incubated
with and without oleate for 4 hours, and the presence of
adiponectin in cell media was analyzed by Western blotting.
Intracellular actin was used as a loading control. (B) Expression
levels of mRNAs for adiponectin, PPARc, and CEBPa in
differentiated 3T3-L1 adipocytes incubated in the presence and
in the absence of 500 mM of oleate for 4 hours. mRNA was
analyzed by quantitative PCR and normalized by 36B4. Data
were expressed as mean 6 S.D. * p,0.05.
(TIFF)
Figure S2 The effect of palmitate and tunicamycin on
adiponectin secretion. Differentiated 3T3-L1 adipocytes were
incubated with 500 mM of palmitate or 2 mg/ml of tunicamycin
for indicated periods of time, and the presence of adiponectin in
cell media was analyzed by Western blotting. Intracellular actin
was used as a loading control.
(TIFF)
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